# A Prospective Trial to Reduce Post-Operative Pain in Implant Based Breast Reconstruction

> **NCT02044302** · PHASE2 · TERMINATED · sponsor: **Yale University** · enrollment: 2 (actual)

## Conditions studied

- Post-operative Pain

## Interventions

- **DRUG:** Bupivacaine
- **DRUG:** Botulinum Toxins
- **DRUG:** Analgesics

## Key facts

- **NCT ID:** NCT02044302
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-04
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2017-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02044302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02044302, "A Prospective Trial to Reduce Post-Operative Pain in Implant Based Breast Reconstruction". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02044302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*